[18F]FLT-PET as a Predictive Imaging Biomaker of Treatment Responses to Regorafenib
NCT02175095
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
68
Enrollment
OTHER
Sponsor class
Conditions
Colorectal Cancer
Interventions
DRUG:
Regorafenib
DIAGNOSTIC_TEST:
[18F]FLT-PET
DIAGNOSTIC_TEST:
[18F]FDG-PET
Sponsor
Asan Medical Center